Two businesses, one building, and a plan for four more.

What we own

Two businesses, one building

Why this model

A building with two doors, instead of two buildings

The street frontage at 231 Dundas St E, drawn flat and to scale along its length from the proposed floor plan approved on 31 August 2026: 21 ft 6 in of street elevation plus a 26 ft 4 in angled run, 47 ft 10 in altogether. Both exterior doors are where the plan’s own dimension chains put them, and those two chains close to within two millimetres, which is why they can be trusted. Door centre to door centre, measured along the frontage, is 9,207 mm — about 30 ft. The figure is drawn at the same scale.

Prescribing and dispensing thirty seconds apart

Most of what makes ongoing treatment fail is friction — a second trip across the city, a fax that never arrives, a prescription that runs out before anyone notices. When the person writing it and the person filling it are in the same building, that whole category of failure gets smaller.

Compounding is the part of pharmacy that is hard to copy

A compounding lab is capital, roughly a year of regulatory work, and a pharmacist who knows how to run one. That is why most pharmacies do not have one, and why somebody who needs a custom-strength preparation gets sent elsewhere and waits.

The licence is the barrier, and we are going through it the slow way

A pharmacy in Ontario needs accreditation from its College and a pharmacist who owns a majority of it. A clinic has to be structured the way the College of Physicians and Surgeons requires. Those rules are slow, and that is the point.

The demand is demographic, not a forecast

Ontario’s population is projected to grow by roughly 30% by 2046, and the share of Canadians over 65 keeps climbing. Both show up in the same place: more prescriptions, more chronic conditions to manage, more people looking for a family doctor and not finding one.

The rest of the reasoning, and the five-phase plan →